Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year | Award Type | Project # | RFA # | PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2006 | U43 | CA122745 | RFA-CA-06-006 | BALGLEY, BRIAN M. | CALIBRANT BIOSYSTEMS, INC. | BREAST CANCER PROTEOMIC VIA LASER-FREE MICRODISSECTION AND GEMINI TECHNOLOGIES | Complete |
2023 | R61 | CA278531 | RFA-CA-22-001 | SHIRURE, VENKTESH | UNIVERSITY OF CALIFORNIA AT DAVIS | Microfluidic technology to isolate tumoricidal T-cells from peripheral blood | Active |
2023 | R61 | CA278398 | RFA-CA-22-001 | GAO, XIAOJING J | STANFORD UNIVERSITY | Program the Immune System against RAS-driven Cancer | Active |
2023 | R61 | CA278452 | RFA-CA-22-001 | SHAH, NEEL H | COLUMBIA UNIV NEW YORK MORNINGSIDE | A Generalizable Photo-Crosslinking Strategy to Identify Tyrosine Phosphatase Substrates | Active |
2023 | R61 | CA278445 | RFA-CA-22-001 | DHAKAL, SOMA | VIRGINIA COMMONWEALTH UNIVERSITY | Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers | Active |
2023 | R61 | CA278559 | RFA-CA-22-001 | LU, YUE | UNIVERSITY OF UTAH | Vesicle Epitope Transcript sequencing (VET-seq): Droplet-based Multiomic Profiling Platform for Single Vesicle Analysis | Active |
2023 | R61 | CA278459 | RFA-CA-22-001 | PRATX, GUILLEM | STANFORD UNIVERSITY | A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer | Active |
2023 | R61 | CA281795 | RFA-CA-22-001 | CAMPAGNOLA, PAUL J | UNIVERSITY OF WISCONSIN-MADISON | A novel multimodal ECM analysis platform for tumor characterization combining morphological and spectrochemical tissue imaging approaches. | Active |
2023 | R61 | CA281807 | RFA-CA-22-001 | HACOHEN, NIR | BROAD INSTITUTE, INC. | Development of methods for highly multiplexed quantification of cancer proteomes using large-scale nanobody libraries | Active |
2023 | R61 | CA278558 | RFA-CA-22-001 | YAN, HAO | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | High-throughput, purification-free, and ultrasensitive transmembrane nanosensor arrays for digital counting of microRNA biomarkers of intact exosomes | Active |
2023 | R61 | CA281657 | RFA-CA-22-001 | LUKER, GARY D | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Integrated Imaging Tools for Intercellular Chemokine Signalling | Active |
2023 | R61 | CA278402 | RFA-CA-22-001 | BRAVO CORDERO, JOSE JAVIER | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | Intersectional genetics-based biosensors for dormant cancer cells | Active |
2008 | R44 | CA134258 | RFA-CA-07-039 | GUO, BAOCHUAN | GLC BIOTECHNOLOGY, INC. | MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY | Complete |
2008 | R44 | CA134310 | RFA-CA-07-041 | LEE, BRIAN W | IMMUNOCHEMISTRY TECHNOLOGIES, LLC | NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO | Complete |
2006 | R44 | CA118785 | RFA-CA-06-006 | BROWN, DAVID M | AMBION DIAGNOSTICS, INC. | MIRNA PROFILING IN FIXED CANCER SAMPLES | Complete |
2008 | R44 | CA114126 | RFA-CA-07-039 | LIM, MARK | AMBERGEN, INC | ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE | Complete |
2006 | R44 | CA097569 | RFA-CA-06-005 | BRADY, ERIK D | MICROCOSM, INC. | ENHANCED CANCER MICROARRAY | Complete |
2008 | R44 | CA120619 | RFA-CA-07-041 | LEE, PHILIP J | CELLASIC CORPORATION | MICROFLUIDIC PLATFORM FOR CANCER CELL CULTURE AND ANALYSIS | Complete |
2006 | R44 | CA121155 | RFA-CA-06-005 | LU, PETER S. | ARBOR VITA CORPORATION | A NOVEL DIAGNOSTIC ASSAY FOR ONCOGENIC HUMAN PAPILLOMAVIRUSES | Complete |
2020 | R44 | CA247353 | PAR-18-303 | FRIEDA, KIRSTEN | SPATIAL GENOMICS, INC. | Spatial and single cell analysis of tumor microenvironment by seqFISH+ | Complete |
2008 | R44 | CA118785 | RFA-CA-06-006 | BROWN, DAVID M | AMBION DIAGNOSTICS, INC. | MIRNA PROFILING IN FIXED CANCER SAMPLES | Complete |
2008 | R44 | CA128858 | RFA-CA-07-008 | DOLINGER, DAVID LEE | IQUUM, INC. | RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS | Complete |
2021 | R44 | CA261523 | PAR-18-303 | HUNG, PAUL JU-SUNG | COMBINATI, INC. | Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring | Complete |
2016 | R44 | CA199194 | PAR-13-327 | KARSTEN, STANISLAV | NEUROINDX INC. | Automated Platform for Fixed Tissue Microdissection | Complete |
2020 | R44 | CA243990 | PAR-18-303 | GURARD-LEVIN, ZACHARY | SAMDI TECH, INC. | Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities | Complete |
2016 | R44 | CA187852 | PAR-13-327 | JOHNSON, DAVID SCOTT | GIGAGEN, INC. | Next-Generation Antibody Discovery and Development Technology | Complete |
2009 | R44 | CA140047 | RFA-CA-08-011 | CHEN, WEN-TIEN | VITATEX, INC. | CANCER PROGENIYOR CELL MARKERS | Complete |
2004 | R44 | CA081903 | PAR-01-106 | TS'O, PAUL O. P. | CCC DIAGNOSTICS, LLC | CLINICAL STUDIES OF CIRCULATING EPITHELIAL CANCER CELLS | Complete |
2009 | R44 | CA115041 | RFA-CA-08-013 | ZOU, NIANXIANG | BIO-QUICK CORPORATION | DEVELOPMENT OF ULTRASOUND-FACILITATED FORMALIN-FIXED AND PARAFFIN-EMBEDDED TISSUE | Complete |
2020 | R44 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues | Complete |
2004 | R44 | CA105539 | PAR-01-105 | BATTRELL, CHARLES FRED | MICRONICS, INC. | MICROFLUIDIC POINT-OF-CARE CANCER CELL ANALYZER | Complete |
2001 | R44 | CA081952 | PAR-99-101 | CHEE, MARK S. | ILLUMINA, INC. | RANDOM ARRAYS FOR GENE EXPRESSION PROFILING | Complete |
2004 | R44 | CA107988 | PAR-01-105 | BALGLEY, BRIAN M | CALIBRANT BIOSYSTEMS, INC. | INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS | Complete |
2009 | R44 | CA130026 | RFA-CA-07-010 | LEVENSON, RICHARD M. | CAMBRIDGE RESEARCH AND INSTRUMENTATION | CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING | Complete |
2001 | R44 | CA081965 | PAR-99-101 | BITTER, GRANT A. | BITTECH, INC. | DNA MISMATCH REPAIR FUNCTIONAL GENETIC TESTS | Complete |
2004 | R44 | CA099126 | PAR-01-105 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | ARTIFICIAL ANTIBODY MIMETICS | Complete |
2009 | R44 | CA134258 | RFA-CA-07-039 | GUO, BAOCHUAN | GLC BIOTECHNOLOGY, INC. | MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY | Complete |
2001 | R44 | CA083396 | PAR-99-101 | GITE, SADANAND | AMBERGEN, INC | NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION | Complete |
2004 | R44 | CA099333 | PAR-01-105 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | INSTRUMENTATION FOR HIGH-RESOLUTION ANALYSIS OF CANCER | Complete |
2009 | R44 | CA134310 | RFA-CA-07-041 | LEE, BRIAN W | IMMUNOCHEMISTRY TECHNOLOGIES, LLC | NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO | Complete |
2001 | R44 | CA083598 | PAR-99-101 | RAO, CHANDRA | IMMUNICON CORPORATION | ANALYSIS OF CIRCULATING CANCER CELLS EARLY IN DISEASE | Complete |
2007 | R44 | CA128858 | RFA-CA-07-008 | DOLINGER, DAVID LEE | IQUUM, INC. | RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS | Complete |
2014 | R44 | CA161965 | PAR-13-327 | LIM, MARK | AMBERGEN, INC | GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS | Complete |
2003 | R44 | CA084804 | PAR-01-104 | GOLOVLEV, VAL V | SCI-TEC, INC. | MAGNETICALLY READABLE MICROARRAY | Complete |
2009 | R44 | CA118785 | RFA-CA-06-006 | SCHWARZBACH, ANNA | ASURAGEN, INC. | MIRNA PROFILING IN FIXED CANCER SAMPLES | Complete |
2001 | R44 | CA088684 | PAR-99-101 | LEVENSON, RICHARD M. | CAMBRIDGE RESEARCH AND INSTRUMENTATION | SIMPLE, LOW-COST, ULTRA-RAPID SPECTRAL IMAGING PLATFORM | Complete |
2007 | R44 | CA130026 | RFA-CA-07-010 | LEVENSON, RICHARD M. | CAMBRIDGE RESEARCH AND INSTRUMENTATION | CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING | Complete |
2010 | R44 | CA133987 | RFA-CA-08-011 | DUFFY, DAVID C | TWIN LIGHTS BIOSCIENCE, INC. | SINGLE MOLECULE FIBER ARRAYS FOR THE DETECTION OF LOW ABUNDANCE PROTEINS | Complete |
2010 | R44 | CA140047 | RFA-CA-08-011 | CHEN, WEN-TIEN | VITATEX, INC. | CANCER PROGENIYOR CELL MARKERS | Complete |
2017 | R44 | CA188154 | PAR-13-327 | PREMSRIRUT, PREM KHOVABUTR | MIRIMUS, INC. | Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research | Complete |